Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
11551
PUT
Apollo Commercial Real Estate
ARI
$876M
| $139K | ﹤0.01% |
13,700
-46,700
| -77% | -$476K |
|
11552
PUT
CytomX Therapeutics
CTMX
$734M
| $139K | ﹤0.01% |
43,500
-62,500
| -59% | -$141K |
|
|
ABX
11553
PUT
Abacus Global Management
ABX
$998M
| $139K | ﹤0.01% |
24,200
-28,700
| -54% | -$170K |
|
11554
PUT
Avalo Therapeutics
AVTX
$989M
| $139K | ﹤0.01% |
+10,900
| New | +$93.7K |
|
11555
InflaRx
IFRX
$253M
| $138K | ﹤0.01% |
+102,951
| New | +$109K |
|
11556
PUT
Zura Bio
ZURA
$542M
| $138K | ﹤0.01% |
+31,800
| New | +$57.2K |
|
11557
Jerash Holdings
JRSH
$63.9M
| $138K | ﹤0.01% |
41,450
+10,912
| +36% | +$36.7K |
|
11558
PUT
AerSale
ASLE
$298M
| $138K | ﹤0.01% |
16,800
-6,000
| -26% | -$45.2K |
|
11559
Virgin Galactic
SPCE
$377M
| $137K | ﹤0.01% |
35,542
-74,444
| -68% | -$250K |
|
|
AIRJ
11560
Montana Technologies Corp
AIRJ
$405M
| $137K | ﹤0.01% |
+29,217
| New | +$137K |
|
|
BIOA
11561
PUT
BioAge Labs
BIOA
$501M
| $137K | ﹤0.01% |
23,300
-1,000
| -4% | -$4.68K |
|
11562
Identive
INVE
$61.2M
| $137K | ﹤0.01% |
+39,704
| New | +$142K |
|
11563
CALL
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$18.7M
| $137K | ﹤0.01% |
2,110
+250
| +13% | +$19.4K |
|
11564
PUT
GrowGeneration
GRWG
$88.9M
| $137K | ﹤0.01% |
73,200
+51,300
| +234% | +$70.3K |
|
11565
PUT
Ocugen
OCGN
$420M
| $137K | ﹤0.01% |
83,800
-12,500
| -13% | -$13.8K |
|
|
CAN
11566
CALL
Canaan Creative
CAN
$145M
| $136K | ﹤0.01% |
154,800
-60,600
| -28% | -$46K |
|
|
VIVO
11567
PUT
VivoPower PLC
VIVO
$118M
| $136K | ﹤0.01% |
+30,300
| New | +$156K |
|
|
NFGC
11568
CALL
New Found Gold
NFGC
$607M
| $136K | ﹤0.01% |
57,500
+30,100
| +110% | +$53K |
|
|
VTYX
11569
CALL
DELISTED
Ventyx Biosciences
VTYX
| $136K | ﹤0.01% |
43,800
+800
| +2% | +$2.12K |
|
11570
PUT
Myriad Genetics
MYGN
$304M
| $136K | ﹤0.01% |
18,800
+4,600
| +32% | +$27.3K |
|
|
OYSEU
11571
Oyster Enterprises II Acquisition Corp Units
OYSEU
$220M
| $135K | ﹤0.01% |
+13,219
| New | +$134K |
|
|
AGNT
11572
CALL
AGNT Inc
AGNT
$690M
| $135K | ﹤0.01% |
12,700
-15,300
| -55% | -$162K |
|
|
PHLT
11573
CALL
DELISTED
Performant Healthcare Inc
PHLT
| $135K | ﹤0.01% |
17,500
+6,200
| +55% | +$39.5K |
|
|
LAR
11574
PUT
Lithium Argentina AG
LAR
$1.08B
| $135K | ﹤0.01% |
40,500
-8,100
| -17% | -$24.5K |
|
11575
CALL
Wabash National
WNC
$512M
| $135K | ﹤0.01% |
13,700
-15,900
| -54% | -$170K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.